Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study March 23, 2026 4:30 ...
Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...
AI is rapidly reshaping the landscape of surgical oncology. However, its true potential lies not in isolated tools, but ...
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children and adults.
An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...
Circulating tumor DNA (ctDNA) as a real-time biomarker in marker-negative germ cell tumors (GCT): A proof-of-concept study. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers ...
Annual Financial Report. PR Newswire. LONDON, United Kingdom, March 24. 24 March 2026 . Keller Group plc . Annual Report and Accounts for the year ended 31 Dece ...
Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...
TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more ...
New plans are underway to transform the community surrounding the Ravenswood Generating Station in Long Island City, Queens. It comes alongside efforts to turn the natural gas power plant into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results